Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Troglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Pancreatic Neoplasms 1 Liposarcoma 1 Diabetes Mellitus, Type 2 1

Interventions

Doxorubicin 25 Radiotherapy 15 Ifosfamide 14 Trabectedin 10 pazopanib 6 ribociclib 5 pembrolizumab 5 Specimen Handling 5 Gemcitabine 5 Biopsy 5 palbociclib 4 Magnetic Resonance Spectroscopy 4 Docetaxel 4 Cyclophosphamide 4 Chemotherapy, Adjuvant 4 selinexor 3 liposomal doxorubicin 3 eribulin 3 X-Rays 3 Vincristine 3 Radiation 3 Neoadjuvant Therapy 3 Imatinib Mesylate 3 Filgrastim 3 Etoposide 3 toripalimab 2 temsirolimus 2 romidepsin 2 pegfilgrastim 2 cixutumumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003058 2017-02-13

Troglitazone in Treating Patients With Liposarcoma

Dana-Farber Cancer Institute

Phase 2 Completed

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡